SGLT2 inhibitors block the reabsorption of glucose by inhibiting SGLT2, thereby promoting glucose renal excretion; this lowers the elevated glucose levels of patients with diabetes and produces an osmotic diuretic effect [4]. Here, SLC5A2 is linked to diabetes mellitus.